GS-100 d amsujji n AAV9 i d-yettakken asnas n gen NGLY1 n wemdan. Yewwi-d usegmi n ddwa ur nlaq ara seg Uḥuddu n Yiɣlanen d Yiɣlanen n Marikan d Tuddsa n Yiɣlanen n Marikan (EMA). Terapi-ya tewwi-d daɣen asegmi n waṭṭan ur nlaq ara n warrac n FDA deg 2021 d usegmi n ubrid s tɣawla aseggas yezrin.
#SCIENCE #Kabyle #CU
Read more at Clinical Trials Arena